Modulating the RNA processing and decay by the exosome: Altering Rrp44/Dis3 activity and end-product by Reis, Filipa P. et al.
Modulating the RNA Processing and Decay by the
Exosome: Altering Rrp44/Dis3 Activity and End-Product
Filipa P. Reis1, Ana Barbas1¤a, A. A. Klauer-King2, Borislava Tsanova2, Daneen Schaeffer2¤b,
Eduardo Lo´pez-Vin˜as3,4, Paulino Go´mez-Puertas3, Ambro van Hoof2, Cecı´lia M. Arraiano1*
1 Instituto de Tecnologia Quı´mica e Biolo´gica - ITQB, Universidade Nova de Lisboa, Oeiras, Portugal, 2 Department of Microbiology and Molecular Genetics, and The
University of Texas Graduate School of Biomedical Sciences, University of Texas Health Science Center-Houston, Houston, Texas, United States of America, 3 Centro de
Biologia Molecular ‘‘Severo Ochoa’’ (CSIC-UAM), Campus Universidad Autonoma de Madrid, Madrid, Spain, 4 Biomol-Informatics SL, Madrid, Spain
Abstract
In eukaryotes, the exosome plays a central role in RNA maturation, turnover, and quality control. In Saccharomyces
cerevisiae, the core exosome is composed of nine catalytically inactive subunits constituting a ring structure and the active
nuclease Rrp44, also known as Dis3. Rrp44 is a member of the ribonuclease II superfamily of exoribonucleases which include
RNase R, Dis3L1 and Dis3L2. In this work we have functionally characterized three residues located in the highly conserved
RNB catalytic domain of Rrp44: Y595, Q892 and G895. To address their precise role in Rrp44 activity, we have constructed
Rrp44 mutants and compared their activity to the wild-type Rrp44. When we mutated residue Q892 and tested its activity in
vitro, the enzyme became slightly more active. We also showed that when we mutated Y595, the final degradation product
of Rrp44 changed from 4 to 5 nucleotides. This result confirms that this residue is responsible for the stacking of the RNA
substrate in the catalytic cavity, as was predicted from the structure of Rrp44. Furthermore, we also show that a strain with a
mutation in this residue has a growth defect and affects RNA processing and degradation. These results lead us to
hypothesize that this residue has an important biological role. Molecular dynamics modeling of these Rrp44 mutants and
the wild-type enzyme showed changes that extended beyond the mutated residues and helped to explain these results.
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Introduction
The exosome is an important protein complex involved in the
maintenance of the correct levels of RNAs in the cell [1,2]. The
exosome processes some RNAs to shorter forms and participates in
RNA degradation and surveillance. It is a highly conserved
complex present in both eukaryotes and Archaea. The yeast
exosome is a complex that consists of a core of ten proteins that are
essential for viability and operates in the nucleus and in the
cytoplasm [3]. Previous reports have shown that Rrp44 (also
known as Dis3) is the only catalytically active nuclease in the yeast
core exosome [4,5] and plays a direct role in RNA surveillance
contributing to the recognition and degradation of specific RNA
targets [6]. Rrp44 is a member of the RNase II family of enzymes,
since it has the RNB catalytic domain and is closely related to the
39 hydrolytic exoribonucleases RNase II and RNase R from
Escherichia coli [7,8]. This family of proteins is ubiquitous and these
enzymes can be found in all three domains of life. Members of this
family are often essential for growth [9] and can be developmen-
tally regulated [10]. In Schizosaccharomyces pombe both Dis3 and
Dis3L2 are present but Saccharomyces cerevisiae only has Rrp44/Dis3
[11]. Dis3L2 preferentially degrades uridylated substrates and has
defined a novel cytoplasmic decay pathway, independent of the
exosome, which can degrade not only mRNAs but also other types
of RNAs such as miRNAs [11–13]. In humans there are 3
homologues: Dis3, Dis3L1 and Dis3L2 [14,15]. Mutations in
Rrp44/Dis3 homologues cause abnormal chloroplast biogenesis
[16], aberrant mitotic control, and human diseases such as
multiple myeloma and Perlman syndrome [17–19].
The determination of the structure of RNase II provided an
explanation for the dynamic mechanism of RNA degradation for
this family of enzymes [7]. Rrp44 presents a similar modular
organization to E. coli RNase II, consisting of a central nuclease
domain (RNB) flanked by three oligonucleotide binding domains,
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two at the N-terminus and one at the C-terminus [7,20]. In
addition to these domains, yeast Rrp44 contains a conserved motif
at the N-terminus that contains three conserved cysteine residues -
CR3, and a highly conserved PIN domain [10,20,21]. We have
recently shown that the three cysteines together with an histidine
from the PIN domain affect the binding to the exosome [22]. We,
and others have shown that in addition to the already known
Rrp44 exonucleolytic activity, Rrp44 also has endonucleolytic
activity associated with its PIN domain [23–25].
In order to ensure proper cellular RNA metabolism, the
eukaryotic exosome needs to be tightly regulated. However, it is
still unclear how the activity of the exosome is controlled. To
address whether the exosome subunits or the exosome cofactors
are responsible for the regulation of this macromolecular complex,
we focused initially on the biochemical characterization of yeast
Rrp44, and generated several mutants in conserved residues. A
previous study of RNase II showed that a mutation in E542
resulted in a ‘‘super-enzyme’’ with a significant increase in
ribonucleolytic activity [26]. In other studies it was also shown
that Y253 in RNase II and Y324 in RNase R are critical in setting
the size of the end-product in in vitro experiments [27,28]. The
crystal structure of yeast Rrp44 suggests that Y595 plays a similar
role, but its function has not been experimentally addressed
[20,21]. To investigate whether the size of the end-product is




Restriction enzymes, T4 DNA ligase and T4 polynucleotide
kinase were purchased from Fermentas. Phusion DNA polymerase
is from Finnzymes. Unlabeled oligonucleotide primers were
synthesized by STAB Vida, Portugal.
E. coli Strains
The E. coli strains used were XL1-Blue (recA1 endA1 gyrA96 thi-1
hsdR17 supE44 relA1 lac [F9 proAB lacIqZDM15 Tn10 (Tetr)];
Stratagene) for cloning experiments, and Rosetta(DE3)pLysS (F2
ompT hsdSB(rB
2 mB
2) gal dcm (DE3) pLysSRARE (CamR);
Novagen) for expression and purification of enzymes.
Construction of rrp44 Mutants by Site-Directed
Mutagenesis
The point mutations Q892A and Y595A were introduced into
pGEX-RRP44 and pRS415- RRP44 [24] by site-directed mutagen-
esis. The oligonucleotides used in this study were the following
(base changes are indicated in lower case letters): forward
oligonucleotide Q892Aa, 59-CAGAAACGCCgcATTCGCCGG-
TAGGGCTaGCATAG-39 and reverse oligonucleotide Q892Ab,
59-ATGCtAGCCCTACCGGCGAATgcGGCGTTTCTGTG-
39; forward oligonucleotide Y595Aa, 59-GGTACTTCTG-
TAgcTTTGGTcGAC-39 and reverse oligonucleotide Y595Ab,
59-GTCgACCAAAcgTACAGAAGTACC-39; forward oligonu-
cleotide G895Aa, 59-CGCCCAATTCGCCGcTAGGGCtAGC-
39 and reverse oligonucleotide G895Ab, 59-GCTaGCCC-
TAgCGGCGAATTGGGCG-39; forward oligonucleotide
G895Ea, 59-CGCCCAATTCGCCGaaAGGGCtAGC-39 and re-
verse oligonucleotide G895Eb, 59- GCTaGCCCTttCGGC-
GAATTGGGCG-39; forward oligonucleotide G895Qa, 59-
CGCCCAATTCGCCcaaAGGGCtAGC-39 and reverse oligonu-
cleotide G895Qb, 59-GCTaGCCCTttgGGCGAATTGGGCG-
39. Each oligonucleotide also changes a restriction site. We
screened putative mutants by restriction digestion and verified
them by sequencing at STAB Vida, Portugal.
Overexpression and Purification of Wild-Type Rrp44 and
Mutants
Wild-type and mutated Rrp44 fused to GST were expressed in
the Rosetta(DE3)pLysS E. coli strain. Cultures were grown in 2
liters TB medium supplemented with 200 mg ml21 ampicillin and
34 mg ml21 chloramphenicol at 30uC to an optical density at
600 nm (OD600) of 1.2 and then induced expression by addition of
0.2 mM IPTG and finally incubated overnight at 18uC. Cells were
harvested by centrifugation and subsequently the pellets were
frozen. Cells were thawed on ice, resuspended in 30 ml PBS
buffer, pH 7.3, with 10 mM DTT and 1 mM PMSF, and lysed
using the French Press. The crude extracts were treated with 5
units Benzonase (Sigma) for 30 min, and clarified by centrifuga-
tion at 10,000 g for 30-min. The clarified protein extract was
loaded onto a GSTrapTM FF 1-ml column (GE healthcare),
previously equilibrated in binding buffer. Proteins were eluted with
50 mM Tris-HCl, pH 8.2, 10 mM reduced glutathione. Fractions
containing the purified protein were pooled and loaded onto a
HiTrapTM Q FF column (GE Healthcare), previously equilibrated
in 50 mM Tris-HCl, pH 8.2. Proteins were then eluted with a 0–1
M NaCl gradient in 50 mM Tris-HCl, pH 8.2, 1 mM DTT. The
eluted protein was concentrated by centrifugation at 4uC with
Vivaspin 500 Centrifugal Concentrators (Vivaspin). The protein
concentrations were determined by spectrophotometry using a
NanoDrop 1000 instrument (Alfagene) and 50% (v/v) glycerol and
1 mM DTT was added to the final fractions before storage at
220uC.
Substrate Preparation
Exoribonucleolytic activity was assayed using different RNA
oligoribonucleotides as substrates: a 30-mer oligoribonucleotide
(59-CCCGACACCAACCACUAAAAAAAAAAAAAA-39) as a
single-stranded substrate and a 30-mer oligoribonucleotide (59-
CCCGACACCAACCACUAAAAAAAAAAAAAA-39) annealed
to the complementary 16-mer oligoribonucleotide (59-AGUG-
GUUGGUGUCGGG-39) as a double-stranded substrate with a
39-single-stranded extension. The 30-mer RNA oligoribonucleo-
tide was labeled at the 59-end with [c-32ATP] and T4
polynucleotide kinase and further purified with MicroSpin G-25
columns (GE Healthcare) to remove the non-incorporated
nucleotides. The hybridization between 16-mer and the radioac-
tively labeled 30-mer oligomer was performed in a 1:1.3 (mol:mol)
ratio in a buffer containing 10 mM Tris-HCl (pH 8.0) and 20 mM
KCl. The mixture was then incubated at 95uC for 7 min and
allowed to cool slowly to 4uC. Formation of the double stranded
substrate was confirmed on a native polyacrylamide gel.
RNase Assays
Exoribonuclease activity assays were performed in a final
volume of 25 ml containing 20 nM of enzyme in the reaction
buffer: 10 mM Tris-HCl pH 8, 75 mM KCl, 40 mM MgCl2 and
1 mM b-mercaptoethanol [4]. Control reactions were incubated
with no enzyme added. Reactions were started by the addition of
the substrate, directly or supplemented with 40 nM of the non-
radioactive labeled oligonucleotide, and incubated at 37uC.
Samples were withdrawn at the time points indicated in the
figures, and the reaction was stopped by adding an equal volume
of formamide-containing dye supplemented with 10 mM EDTA.
Reaction products were resolved in 20% polyacrylamide, 8M urea
gels. Gels were imaged using STORM 860 Molecular Imager
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scanner (GE Healthcare). The exoribonucleolytic activity of the
enzymes was determined by quantifying the fraction of full-length
RNA lost in distinct experiments using 20 nM of enzyme and 59-
radioactively labeled 30-mer oligoribonucleotide supplemented
with 40 nM of non-radioactively labeled 30-mer oligoribonucleo-
tide. Quantification was carried out using Image Quant software
and each value obtained represents the mean of three independent
assays.
Comparative modelling of wild-type Rrp44 and Q892A
and Y595A mutant proteins
Preliminary 3D-structural models of S. cerevisiae wild-type Rrp44
and mutant proteins Q892A and Y595A, were built by using
standard comparative methods, the software DeepView [29] and
the crystallographic structure of yeast Rrp44 D551N mutant
protein bound to a 10-nucleotide poly(A) RNA strand (Protein
Data Bank code 2VNU) [20]. In order to obtain uninterrupted
theoretical structures of residues 252–1001 of Rrp44, the template
set was partially enriched with segments from the apo form of
Rrp44 D551N (Protein Data Bank code 2WP8) [30]. Only
fragments not affected by conformational changes between apo
and bound states were used for this purpose [20,30]. Overall
structural quality of all rendered models was checked using the
analysis programs Anolea, Gromos and Verify3D provided by
SWISS-MODEL server (http://swissmodel.expasy.org) [31–33].
Modelling of Rrp44 molecular interactions to single-
stranded poly(A) RNA
In order to model 3D-structural interaction of wild-type Rrp44,
and mutants Q892A and Y595A with a single-stranded poly(A)
RNA molecule (RA1–RA10), preliminary structures were set up
by translating the RNA ligand coordinates from the PDB structure
2VNU [20] over each comparative model. The recently published
structure of the Rrp44 D171N/D551N mutant in complex with
poly(U) RNA at the RNB domain [21] was used for comparative
purposes. To obtain a set of refined models, a standard molecular
dynamics protocol of 6 ns was performed for every Rrp44-ssRNA
system, essentially as described elsewhere [26,27]. All the energy
minimizations and molecular dynamics simulations were per-
formed with the PMEMD module of the AMBER11 package [34],
using molecular mechanics parameters in parm99 [34] plus
parm99SBild modifications [35] and ff99bsc0 [36] sets. For every
Rrp44-ssRNA system, one minimized average structure was taken
from the final most stable segment of simulation, as representative
of the whole ensemble. Root-mean-square-deviation (RMSD)
trace analyses of the peptide-backbone in the RNB domain
(residues 475–911), and the phosphate-backbone in nucleotides
RA1–RA5 were determined with the program PTRAJ from the
same Amber suite. All RMSD point values were calculated from
the initial conformation of the three modelled Rrp44-ssRNA
systems. All structures were manipulated and visually rendered
using PyMOL.
Yeast Complementation Assay
An rrp44D strain complemented by wild-type RRP44 on a
plasmid with a URA3 selectable marker was transformed with
LEU2 plasmids encoding each of the point mutations. To test
whether these mutations were essential for growth, the transfor-
mants were serially diluted by a factor of five and spotted onto
plates containing 5-fluoro-orotic acid (5-FOA) or control plates
(SC-LEU-URA). Growth on 5-FOA indicates that the mutated
Rrp44 can carry out the essential function of the exosome.
his3-nonstop Growth Assay
To investigate whether the mutations of Rrp44 disrupt
exosome-mediated mRNA decay we used the two viable Rrp44
mutations in a his3-nonstop growth assay. ski7D [Vector, LEU2],
rrp44D [RRP44, LEU2], rrp44D [rrp44-Q892A, LEU2] and rrp44D
[rrp44-Y595A, LEU2] strains were transformed with a mutant his3
gene lacking a stop codon, on a plasmid with a URA3 marker. The
ski7D strain was included because it is known to stabilize the his3-
nonstop mRNA. The transformants were selected on SC-URA-
LEU, and then serially diluted and spotted on SC-HIS and SC-
URA-LEU plates. Growth on SC-HIS plates indicates a nonstop
mRNA defect.
xrn1D synthetic lethality assay
To further investigate whether the mutations of Rrp44 disrupt
exosome-mediated mRNA decay we also tested for synthetic
lethality with xrn1D, essentially as previously described [37].
Briefly, plasmids encoding the rrp44 point mutations were
transformed into the rrp44D xrn1D strain containing a URA3
plasmid encoding wild-type Rrp44. Transformants were grown in
SC-LEU-URA and serially diluted in 96-well plates by a factor of
five and spotted onto media containing 5-FOA. In the absence of
Xrn1, the exonuclease activity of Rrp44 is solely responsible for
bulk mRNA degradation, and therefore growth on 5-FOA
indicates that the Rrp44 allele on the LEU2 plasmid is capable
of mRNA degradation.
Northern Blot Analysis
The RRP44, rrp44-D171A, rrp44-D551N, rrp6D, rrp44-Q892A,
rrp44-Y595A strains were grown in YPD, total RNA was isolated,
resolved on polyacrylamide gels, and probed with 59 32P-labelled
oligonucleotides for 5.8S processing defects (59-TTTCGC-
TGCGTTCTTCATC-39), 59 ETS degradation defects (59-
CGAACGACAAGCCTACTCG-39), and as a loading control
the RNA subunit of the signal recognition particle (SRP - 59-
GTCTAGCCGCGAGGAAGG-39).
Results
Mutation of Q892 enhances Rrp44 activity
A previous study of E. coli RNase II showed that a mutation in
E542 resulted in a ‘‘super-enzyme’’ with a significant increase in
ribonucleolytic activity [26]. Analysis of both structural and
sequence alignments showed that G895 residue in yeast Rrp44
and E542 in E. coli RNase II occupy the same position (Figure S1,
Figure S2). Thus we chose to mutate G895. Since G895 is not
universally conserved in Rrp44 orthologs, we also targeted Q892.
Q892 is more broadly conserved, one turn away from G895 on the
same alpha helix and chemically more similar to E542 (Figure S1).
Therefore we hypothesized that Rrp44 Q892 might functionally
replace RNase II E542. Thus, mutations G895A, G895E, G895Q,
and Q892A in yeast Rrp44 could be viable candidates to observe
similar effects than those revealed by the RNase II E542A mutant.
In order to analyze the role of these residues we purified the
proteins containing these mutations and compared their activities
to the purified wild-type Rrp44 protein by performing exoribo-
nuclease assays using a 30-mer ssRNA substrate (Figure 1; Figure
S3A, B). As previously demonstrated, the wild-type Rrp44 enzyme
was able to degrade the 30-mer ssRNA substrate to a final major
product of 4 nts [20]. Two of the mutations, G895A and G895Q,
showed a reduction of the ribonucleolytic activity when compared
to the wild-type Rrp44 protein (Figure S3A). The G895E mutant
presented activity very similar to that of the wild-type enzyme.
Most interestingly, the Q892A mutant had a reproducible increase
Modulating Rrp44/Dis3 Activity and End-Product
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in catalytic activity (Figure 1; Figure S3A). Quantitating the
fraction of substrate lost showed that the activity of the Q892A
mutant enzyme was increased more than 2 fold when compared to
its wild-type counterpart (0.56 nmol substrate digested per min per
nmol enzyme versus 0.25 nmol.min21.nmol21; Figure S4).
Similarly to wild-type, Q892A mutant was able to degrade a
double-stranded substrate with a 39 single-stranded extension
(ds16–30) to a final major product of 4 nts (Figure 1B).
Mutation of Y595 alters the Rrp44 end-product
Members of the RNase II family each produce a distinct end-
product, but the length of this product differs between family
members. For example, RNase II and Rrp44 produce 4 nts end
products, but RNase R continues degradation to a 2 nts end
product. The biological significance of these differences is not
understood, but the end product can be changed by mutating a
conserved Y residue. Previous reports showed that a Y253A
mutation in E. coli RNase II changed the end product from 4 to
10 nts, while the equivalent change in E. coli RNase R changed it
from 2 to 5 nts [27,28]. The role of this residue in setting the end
product is thought to be explained by its stabilization of the 39-end
of the RNA molecule in the catalytic site. One of the aims of our
work was to determine the specific role of the equivalent residue in
yeast Rrp44. This residue is highly conserved in the RNase II
family of enzymes and by analysis of the sequence alignment of
RNase II, RNase R and Rrp44 proteins we and others determined
that this specific residue is equivalent to Y595 in yeast Rrp44
[20,28]. We mutated the aromatic residue Y595 in Rrp44 into an
alanine, purified the mutant protein, and assessed its enzymatic
activity (Figure 1; Figure S3B). Our results demonstrate that this
mutation altered the size of the final product of degradation of a
generic substrate. As shown in Figure 1 the major end-product of
Rrp44 is 4 nts in length, while the Y595A mutant produced a
major final product of 5 nts. Our data also suggest that this
mutation resulted in a decrease in catalytic activity (0.25 and
0.05 nmol substrate digested per min per nmol enzyme for the
wild-type and Y595A mutant, respectively; Figure S4).
When a double-stranded substrate with a 39 single-stranded
extension was tested, the same end-product was rendered
(Figure 1B). Comparing with wild-type, the appearance of the
final product is slower in the Y595A mutant and accumulated 19–
22 nt oligomers which shows that this mutant stalls 3–6 nt before
reaching double-stranded structure.
Theoretical structural insights of Rrp44 interaction to
RNA at the RNB domain
In order to understand the molecular basis for the results
obtained, we have generated theoretical structural models. Our
models are based on x-ray structures of Rrp44 either in the RNA
bound [20] or apo [30] form. Importantly, all available
experimentally determined structures are of a catalytically inactive
form (D551N), while our models are of the active enzyme. After
six nanoseconds of free molecular dynamics, representative Rrp44
models for the wild-type, Y595A, and Q892A enzymes showed no
relevant differences in their secondary and tertiary structures.
According to RMSD data, only the ssRNA bound Q892A mutant
shows significant change in its peptide backbone (Figure S5).
However, a detailed inspection of the catalytic cleft provided a set
of interesting local variations that modify ssRNA binding patterns
in the three models.
Figure 1. Exoribonuclease activity of Rrp44 and mutant versions of Rrp44. Activity assays were performed as described in Materials and
Methods using 20 nM of enzyme (WT, Q892A and Y595A) and different substrates. Reactions were stopped and samples were taken at the time-
points indicated. Length of substrates and degradation products are indicated in the figure. In panel A, 30-mer 59-radioactively labeled RNA substrate
(59-CCCGACACCAACCACUAAAAAAAAAAAAAA-39) was supplemented with 40 nM of substrate nonlabeled. In panel B, 30-mer 59-radioactively
labeled RNA substrate (59-CCCGACACCAACCACUAAAAAAAAAAAAAA-39) was annealed with a RNA oligonucleotide (59-AGUGGUUGGUGUCGGG-39).
Figure on the right side depicts the control of the annealing of the double-stranded (ds) substrate on a native polyacrylamide gel.
doi:10.1371/journal.pone.0076504.g001
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Wild-type model. The modeled structure of wild-type Rrp44
suggests that the general pattern of interactions between its RNB
domain and the five most 39 ssRNA nucleotides (RA1–RA5)
remains functionally identical to the one in the D551N RNA-
bound crystal structures, but our model suggest several additional
contacts not present in the crystal structure of the D551N mutant
enzyme (Figure 2A) [20,21]. Specifically, in our model Y654
contributes to binding of the phosphate group of the outgoing
nucleotide (RA1), as well as the 29-OH moiety of nucleotide RA2.
Interestingly, the equivalent RNase II residue (Y313) occupies a
similar position and was suggested to contribute to catalysis by
facilitating protonation of the 39OH of RA2 [13]. The contribu-
tion of R847 to binding the phosphate group of RA1 also seems to
be reinforced in the model. Additionally, our model indicates that
residue N724 can form hydrogen-bonds with the 29-OH group
and the ribose ring of RA2, contributing to stability of the
nucleotide preceding the bond to be broken. Finally, the side chain
of Q892 is hydrogen-bonded to nucleotide RA5, contributing to
stabilize the poly(A) chain at this spot. Overall, comparison of our
model of the wild-type enzyme to the experimentally determined
structures of the D551N mutant suggests a strengthening of the
interactions between Rrp44 and nucleotides RA1, RA2 and RA5.
Clarifying the importance of these interactions will require further
structural, biochemical and genetic experiments.
Q892A mutant model. We analysed Q892 hypothesizing
that it might function similarly to E542 of RNase II. However,
unlike the hydrogen bonding of E542 to the base of RA1, the
amide group of Q892 forms a hydrogen-bond to the backbone of
nucleotide RA5, which cannot be formed upon mutating this
residues to A (Figure 2B). However, our model suggests additional
changes in the catalytic cleft, resulting in weaker and more labile
substrate binding than in the wild-type model and D551N
structures [20,21]. For example, the side chain of Y654 has
moved away from the ssRNA and now could be too far away
(beyond 4.0 Angstroms) to form a strong hydrogen-bond. In
addition, the side chain orientation of R847 resembles that seen in
the D551N structure and its electrostatic interaction with the
phosphate-backbone of RA1 nucleotide could be relaxed [20,21].
However, despite that the Q892A mutation could weaken some
direct interactions, the continuous self-stacking organization of
nucleotides RA1–RA5 to Y595 is maintained. Therefore, the
model of the Q892A protein is consistent with its near wild-type
ability to bind ssRNA in a catalytically active form. The increased
lability may explain the enhanced activity of this mutant.
Y595A mutant model. Analyses of the catalytic cleft of the
Y595A model suggests that this mutation distorts the continuity of
self-stacking interaction between the five most 39 ssRNA
nucleotides (RA1–RA5; Figure 2C). Although nucleotides RA5-
RA3 are organized similarly to the wild-type enzyme, stacking
between RA3 and RA2 is disrupted while RA1 remains stacked on
RA2. Other hypothetical changes in the catalytic cleft suggest that
a general easing of interactions with nucleotides RA2–RA5 might
take place. For example, in contrast to the wild-type model and the
D551N mutant structures [20,21], the side chain of E700 in
Y595A mutant would be exposed to solvent, unable to stabilize the
adenine base in nucleotide RA3. At the same time, N724 does not
seem to directly contact ssRNA in this mutant, but it still
contributes to the position of Y654 which is bound to the 29-OH
moiety of RA2. These alterations in continuity of p-stacked
interactions combined with the easing of strong interactions with
RA2 and RA3 could result in an increase in the lability of
nucleotides RA2–RA5, reduce the stability of substrates smaller
than 6 nucleotides, and consequently hinder catalysis with such
fragments. However, other relevant changes in the local environ-
ment of the outgoing nucleotide (RA1) indicate that its tight
binding would be preserved during the catalytic events. For
example, rather than being exposed to solvent, the base of RA1
could be interacting with the backbone carbonyl oxygen of S593,
and a stronger electrostatic interaction (in terms of distance to
phosphate group) of R847 with the phosphate in RA1 could also
be possible.
Assessing the functions in vivo of the Q892 and Y595
residues
In order to test whether the changes in activity affect the
function of the exosome in vivo, we performed growth assays with
the rrp44-Q892A and rrp44-Y595A mutants. An rrp44D strain
complemented with wild-type RRP44 on a plasmid with a URA3
selectable marker was transformed with LEU2 plasmids encoding
each of the two point mutations, Q892A and Y595A. The empty
vector and a plasmid with the wild-type RRP44 gene were used as
negative and positive controls, respectively. Transformants were
spotted onto plates containing 5-fluoro-orotic acid (5-FOA), which
kills cells that contain the URA3 plasmid. Growth on 5-FOA
indicates that the URA3-RRP44 plasmid was lost and that the
mutated Rrp44 encoded on the LEU2 plasmid can carry out the
essential function of the exosome. As compared to the wild-type
RRP44, the mutant rrp44-Q892A strain does not have an obvious
growth defect, suggesting that this mutation does not affect the
essential function of the exosome in vivo (Figure 3). In contrast, the
strain containing the rrp44-Y595A version is viable, but grows
significantly slower than the wild-type strain. Instead the growth
rate of the rrp44-Y595A strain was comparable to that of the
catalytically dead rrp44-D551N mutant. The growth defect of the
rrp44-Y595A mutant suggests an important biological role for the
Y595 residue that may be related to the alteration of the end-
product induced by this mutation.
Q892A and Y595A mutations do not affect mRNA decay
We used two assays to investigate the effect of the Rrp44
mutations on mRNA degradation. First, inactivation of the
cytoplasmic exosome results in the stabilization of transcripts that
lack stop codons [38,39]. To investigate whether the Q892A or
Y595A mutations affect exosome-mediated mRNA decay, we
analyzed the expression of a his3-nonstop reporter [39]. The
aberrant his3-nonstop mRNA is normally rapidly degraded by the
cytoplasmic exosome. This results in low levels of His3 protein,
and a failure to grow in the absence of histidine. A defect in
nonstop mRNA decay results in growth on media lacking histidine
due to stabilization of the his3-nonstop mRNA. As previously
described, deletion of the gene encoding the cytoplasmic exosome
cofactor Ski7 allowed for growth on media lacking histidine; an
important control showing that the his3-nonstop mRNA transcript
was stabilized in this strain [39]. In contrast, the wild-type strain
and both mutants of RRP44 (rrp44-Q892A and rrp44-Y595A) failed
to grow on the plate without histidine (Figure 4A). Thus, this result
indicates that the his3-nonstop mRNA was unstable and that none
of the mutations in rrp44 affect nonstop mRNA degradation.
In a second assay for mRNA degradation we investigated
synthetic lethality with xrn1D. Unlike nonstop mRNAs, the
degradation of normal mRNAs is mostly carried out by Xrn1
with Rrp44 making a smaller contribution. Therefore, mutations
in Rrp44 do not affect the decay of normal mRNAs, but because
of the redundancy between the pathways the combination of xrn1D
and rrp44 mutations that interfere with normal mRNA decay is
synthetically lethal. Figure 4B shows that the xrn1D rrp44-Q892A
double mutant grows like the xrn1D single mutant, and thus there
is no synthetic lethality. However, the xrn1D rrp44-Y595A mutant
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grows slower than the xrn1D single mutant, but this could be
explained by the slow growth of the rrp44-Y595A single mutant
and not by synthetic lethality. The absence of genetic interactions
suggests that both RRP44 alleles are functional for bulk mRNA
degradation.Y595 is important for RNA-processing and degrada-
tion.
The exosome carries out both RNA-processing and RNA
degradation reactions. To determine if Rrp44 residues Q892 and
Y595 are required for these roles of the nuclear exosome, we
isolated RNA from each mutant strain and analyzed it by
Northern blotting for aberrant processing of the 7S pre-RNA to
5.8S rRNA, and degradation of the 59-external transcribed spacer
(59-ETS). These RNA species are products of the 35S polycistronic
precursor rRNA.
The 5.8S rRNA is generated from a 7S precursor by the
exosome and Mtr4 [40–42]. It was already reported that 7S-
processing intermediates accumulated as a result of the D551N
mutation in the RNB domain but not from the D171A mutation in
the PIN domain [23,24]. In contrast, the rrp6D strain does not lead
to the accumulation of these species, but instead causes the
accumulation of a distinct RNA species that is 30 nucleotides
longer than the normal 5.8S rRNA [42]. Similar to the D551N
mutant, the rrp44-Y595A strain causes the accumulation of
Figure 2. Theoretical catalytic site of Rrp44 RNB domain in S. cerevisiae. Wild-type (panel A) and mutants Q892A (panel B) and Y595A (panel
C), in complex with one single strand poly(A) RNA molecule. Relative locations of some functionally relevant residues described in the text, depicted
over every modeled protein’s 3D structure. Also layed out inside color text boxes, in silico reverted mutation Asp551 (green), Q892A and Y595A
mutations (red), and nucleotide bases (blue) starting from RA1 (outgoing). Hypothetical hydrogen-bond mediated interactions, residue tags and
annotations of corresponding point distances (in Angstroms, measured over every final representative model) depicted in green color. Other
important residues, hypothetically invariant among modeled proteins, not shown for clarity.
doi:10.1371/journal.pone.0076504.g002
Figure 3. The Y595 residue is important for exosome function.
A rrp44D strain complemented by full-length RRP44 on a plasmid with a
URA3 marker was transformed with LEU2 plasmids encoding each of the
mutations. Growth on 5-fluoroorotic acid (5FOA) indicates that rrp44-
Q892A can carry out the essential function of the exosome. Mutation to
alanine of the tyrosine 595 residue reduces growth.
doi:10.1371/journal.pone.0076504.g003
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heterogeneous species that range in length between 7S pre-RNA
and 5.8S rRNA. This indicates that residue Y595 contributes to
the processing of the 5.8S rRNA (Figure 5A).
The 59-ETS is a by-product of rRNA processing which is
degraded by the exosome after cleavage from 35S pre-RNA [40].
Northern blotting using a probe for the 59-ETS revealed the
accumulation of intermediates smaller than 59ETS in rrp44-Y595A
and rrp44-D551N, but not in rrp44-D171A and wild-type RRP44
(Figure 5B). This result is in agreement with previous findings
obtained for the rrp44-D551N and rrp44-D171A strains [23–25].
However, the size of the intermediates accumulated in rrp44-
Y595A strain is different from the ones that accumulate in rrp44-
D551N strain. In addition to the involvement in the maturation of
7S pre-rRNA, the Y595 residue appears to play an important role
in the degradation of the excised 59-ETS pre-rRNA region.
The rrp44-Q892Amutant strain does not show any specific RNA
degradation or processing defects on 7S pre-rRNA, 5.8S rRNA
and 59 ETS, since it always showed the same pattern of
degradation as wild-type RRP44 and rrp44-D171A (Figure 5A,
B). This result is not surprising, since this mutation did not cause a
growth defect phenotype.
Discussion
Mutations in Rrp44 change exosome activity and the size
of the end-product
We performed multiple sequence alignments of RNase II
homologues in order to find which Rrp44 residues corresponded
to E. coli RNase II residues that were shown to be important for
activity and size of the end-product. Both structural and sequence
alignments showed that G895 in yeast Rrp44 is the residue that
occupies the same position as E542 in E. coli RNase II. Previous
studies reported that the carboxylic group of E542 is in close
proximity to the nitrogen atoms of the leaving nucleotide, and the
establishment of one or more hydrogen-bonds between them
could facilitate the elimination of this nucleotide after cleavage of
the RNA substrate by RNase II [26]. Although G895 is in the
same position, it clearly could not carry out this proposed function,
and consistent with this, our results demonstrate that mutations in
the G895 residue do not affect the protein catalytic activity.
Instead of the G or E found in yeast and E. coli, many vertebrate
Rrp44’s have a Q in this position, and all eukaryotic Rrp44’s have
a Q one turn of the helix away (i.e. Q892 in yeast). These Q
residues are a more likely candidate to carry out the same role
ascribed to RNase II E542. Substitution of Q892 by alanine in
yeast Rrp44 (Q892A mutation) led to an increase in ribonucleo-
lytic activity, similar to what happens with the E. coli RNase II
E542A mutant. However, the increase in activity of the Rrp44
Q892A mutant was much more moderate. Interestingly, in our
modeling this Q892 was hydrogen bonded to the phosphate
between RA5 and RA6 instead of to the base of RA1, which may
explain why Q892A in Rrp44 and E542A in RNase II have such
different effect on activity.
Here we report that when Y595 residue is substituted by an
alanine, the in vitro end-product changed from 4 nts to 5 nts. These
data suggest that the role of this aromatic residue in setting the
protein end-product is highly conserved. Moreover, this replace-
ment also resulted in a pronounced decrease in the protein
catalytic activity in vitro and less efficiency in the digestion of
double-stranded structures. The in vitro results may explain the
Figure 4. rrp44-Y595A and rrp44-Q892A do not have a defect in
mRNA decay. A. A ski7D strain [Vector, LEU2], rrp44D [RRP44, LEU2],
rrp44D [rrp44-Q892A, LEU2] and rrp44D [rrp44-Q892A, LEU2] were
transformed with a mutant his3 gene on a plasmid with a URA3
marker. The transformants were selected on SC-URA-LEU. Growth on
SC-HIS indicates that the his3-nonstop mRNA is stabilized while failure
to grow indicates normal nonstop mRNA decay. SC-LEU-URA was used
as control. B. An xrn1D rrp44D strain containing an RRP44, URA3 plasmid
was transformed with LEU2 plasmids that encoded either no Rrp44,
wild-type Rrp44, Rrp44-Q892A or Rrp44-Y595A. Growth on plates
containing 5-FOA indicates that the resulting transformants are viable
upon loss of the URA3 plasmid, and thus that the encoded Rrp44 is
capable of degrading mRNA. SC-LEU-URA was used as control.
doi:10.1371/journal.pone.0076504.g004
Figure 5. Y595 residue is required for both RNA-processing
and degradation. The indicated Rrp44 proteins were expressed in a
rrp44D yeast strain. RNA was isolated from cultures grown in rich
medium and analyzed by northern blotting with probes that hybridize
to the 59 ETS region (panel A), 5.8S rRNA (panel B) and the RNA subunit
of the signal recognition particle (SRP).
doi:10.1371/journal.pone.0076504.g005
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negative effect on exosome function in vivo, since this mutation
does not affect the stability of the protein (data not shown).
Theoretical structural responses and ribonucleolytic
activity
Both substitutions seem to modify the relative organization of
nucleotides RA2–RA5 in the models, making it more labile than
what is expected in the wild-type model presented here. Although
further structural modifications induced by Q892A mutation is
possible, a faster processing capacity could explain the experi-
mentally determined two-fold higher activity. Nevertheless, this
work cannot dismiss the possibility that other changes in the
catalytic complex could in turn modify the energetic barriers,
facilitating the reaction and processing. From an evolutionary
perspective, it is remarkable that the Rrp44 RNB domain has a
wide capacity to accommodate mutations in the catalytic cleft.
Interestingly, by performing undetermined global adaptive con-
formational changes, as in the Q892A model (Figure S5), the
whole protein is able to remain functionally competent despite
possible solvent displacement effects or changes in direct binding
interactions. In relation to the latter hypothesis, our experimental
results on G895A, G895Q, and G895E are also extraordinarily
meaningful, as they show that this position is minimally related or
irrelevant to the structure of protein-RNA-solvent complex.
Nevertheless, more extensive studies involving the other domains
of Rrp44 are still required to generate deeper insights in the fine
structure and dynamics of the RNB-RNA complex during
catalysis. In the Y595A model, an increased lability of nucleotides
RA2–RA5 also seem to induce unsteady bound conformations in
ssRNA substrates smaller than 6 nucleotides, hindering catalysis.
Y595 residue has an important biological role
We showed for the first time that an alteration in Y595 residue
changes the length of the end-product, decreases the activity of the
enzyme and affects the ability to degrade secondary structures.
Moreover, an alteration in this residue was shown to have
implications for the cell, since the strain carrying the Y595A
mutation has an effect in growth phenotype. We suggest that all 3
defects in Rrp44 exonucleolytic activity can contribute to the
growth defect observed in this mutant.
The growth phenotype caused by this mutation also leads us to
hypothesize that the alteration of the size of the end-product leads
to the accumulation of degradation fragments in the cell. In E. coli,
oligoribonuclease (orn gene) is required for the complete degrada-
tion of mRNA to mononucleotides and this process is required for
cell viability [43,44]. Oligoribonuclease has been described as a
single-stranded specific RNase that has strong affinity for small
RNA fragments (2–5 nts), with a 5-mer oligoribonucleotide being
its preferred substrate [43,44]. The 5 nucleotide end-product left
by the Rrp44-Y595A mutant may not be a suitable substrate for
degradation by an unknown yeast oligoribonuclease, and subse-
quently, the accumulation of small RNA fragments might have
toxic effects for the cell and impair cellular growth.
Conclusion
Overall, this study sheds light on the model previously proposed
for Rrp44 activity and mode of action, and allows for an important
step forward in the understanding of the mechanism of RNA
processing and degradation by the exosome. Based on sequence
and structure alignment we predicted that RNase II E542 and
Rrp44 Q892 would also have similar roles, but biochemical
analysis showed that Q892A had a much smaller effect on activity
than expected from the RNase II data, which can be explained by
our modeling suggesting that these two residues have different
roles. Interestingly, Rrp44 Y595 and RNase II Y253 have very
similar roles in the two enzymes, being critical residues in setting
the smallest degradation product. Furthermore, we also show that
a strain with a mutation in this residue has a growth defect and
affects RNA processing and degradation.
Supporting Information
Figure S1 Partial multiple sequence alignment of Rrp44
homologues. The full length sequences of Rrp44 homologues
were aligned using ClustalW (http://www.ebi.ac.uk/Tools/msa/
clustalw2/) and boxshade (http://www.ch.embnet.org/software/
BOX_form.html) with default settings. This figure shows only a
small part of the alignment, in yeast Rrp44 Q892-G895 region.
Positions of yeast Q892 and conserved G895 are indicated. Red:
residues identical in at least half of the sequences. Blue: residues
similar in at least half of the sequences.
(TIF)
Figure S2 Partial multiple structural alignment of
Rrp44 homologues. Superposition of E. coli RNase II (PDB
ID 2IX1) [7] and S. cerevisiae Rrp44 (PDB ID 2VNU) [20] indicates
that residue E.coli E542 and S. cerevisiae G895 residues occupy the
same position in the space. Structures were rendered using
PyMOL.
(TIF)
Figure S3 Exoribonuclease activity of Rrp44 and the
different mutants. (A) Activity assays were performed as
described in Materials and Methods using 20 nM of enzyme and
30-mer 59-radioactively labelled RNA substrate (59-CCCGACAC-
CAACCACUAAAAAAAAAAAAAA-39). Reactions were stopped
and samples were taken at the time-points indicated. Length of
substrates and degradation products are indicated in the figure. (B)
SDS-PAGE analysis of wild-type and Rrp44 mutants. Equal
amounts of mutant proteins were loaded into each lane; the gel
was stained with Coomassie blue for detection.
(TIF)
Figure S4 Exoribonuclease activity of wild-type Rrp44,
Q892A and Y595A mutant. Exoribonucleolytic activity of the
enzymes was determined by quantifying the fraction of full-length
RNA lost using 20 nM of enzyme (WT, Q892A and Y595A) and
59-radioactively labeled 30-mer oligoribonucleotide supplemented
with 40 nM of non-radioactively (59-CCCGACACCAACCA-
CUAAAAAAAAAAAAAA-39). Graphs depict the degradation of
substrate at different time points calculated using Image Quant.
Each value represents the average of three independent assays.
(TIF)
Figure S5 General structural deviations of RNB-ssRNA
theoretical models from yeast Rrp44 wild-type and
mutants. RMSD temporal profiles of RNB domain peptide-
backbones (upper panel) and five most 39 ssRNA nucleotides
(RA1–RA5) phosphate-backbone (lower panel) traces. RMSD
point values and running averages (over 20) plotted in colours red
(wild-type), blue (Q892A) and green (Y595A). RMSD measure-
ments to initial conformations, revealed some interesting differen-
tial responses during the last segment of the simulations (Table S1),
highlighted in soft yellow colour. Data from Rrp44 Q892A suggest
that this mutation might be able to induce significant variability in
the peptide-backbone of the RNB domain, in comparison to the
wild-type and Y595A mutant. On the other hand, little variations
seem to be affecting the phosphate-backbone structure of ssRNA
within the catalytic cleft (nucleotides RA1–RA5) in the three
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phenotypes, although subtle differences could be altering it when
bound to Y595A mutant.
(TIF)
Table S1 Average RMSD values. Average RMSD values
obtained from the last nanosecond of free molecular dynamics
trajectories of the three yeast Rrp44-ssRNA interaction models
calculated. Data correspond to peptide-backbone trace of RNB
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